New hope for kids with tough cancers: first trial of targeted radiation therapy
NCT ID NCT06441331
Summary
This early-stage study aims to find a safe and effective dose of a targeted radiation drug for children and teenagers with specific cancers that have come back or stopped responding to standard treatments. The therapy delivers radiation directly to cancer cells. Researchers will closely monitor how the drug moves through the body and its safety in a small group of participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Universitario Vall d'Hebron - Oncología Médica
RECRUITINGBarcelona, 08035, Spain
Contact Email: •••••@•••••
-
The Children's Hospital of Philadelphia (CHOP)
RECRUITINGPhiladelphia, Pennsylvania, 19104-4319, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.